Changing incidence of myeloproliferative neoplasms in Australia, 2003‐2014-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Changing incidence of myeloproliferative neoplasms in Australia, 2003‐2014

Published:2019-02-12 Issue:4 Volume:94 Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Baade Peter D.¹^ORCID,Ross David M.²³⁴^ORCID,Anderson Lesley A.⁵^ORCID,Forsyth Cecily⁶^ORCID,Fritschi Lin⁷^ORCID

Affiliation:

1. Viertel Cancer Research Centre Cancer Council Queensland Brisbane Queensland Australia

2. Haematology Directorate, SA Pathology Adelaide South Australia Australia

3. Cancer Theme South Australian Health and Medical Research Institute Adelaide South Australia Australia

4. Leukaemia Laboratory, Centre for Cancer Biology University of SA Adelaide South Australia Australia

5. Centre for Public Health and Northern Ireland Cancer Registry Queen's University Belfast United Kingdom

6. Gosford Hospital Gosford New South Wales Australia

7. School of Public Health Curtin University Perth Western Australia Australia

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25407

Reference6 articles.

1. Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12

2. Myeloproliferative neoplasms: trends in incidence, prevalence and survival in Norway

3. Real world epidemiology of myeloproliferative neoplasms: a population based study in Korea 2004–2013

4. Vascular and Neoplastic Risk in a Large Cohort of Patients With Polycythemia Vera

5. A prognostic model to predict survival in 867 World Health Organization–defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology and disease characteristics of myelofibrosis: a comparative analysis between Italy and global perspectives;Frontiers in Oncology;2024-07-24

2. Национальные клинические рекомендации по диагностике и лечению Ph-негативных миелопролиферативных новообразований (истинной полицитемии, эссенциальной тромбоцитемии, первичного миелофиброза) (редакция 2024 г.);Clinical Oncohematology;2024-07-01

3. Laboratory methods of monitoring disease response after allogeneic haematopoietic stem cell transplantation for myelofibrosis;Pathology;2024-02

4. Variability of bone marrow biopsy reporting affects accuracy of diagnosis of myeloproliferative neoplasms: data from the ALLG MPN01 registry;Pathology;2024-02

5. The incidence of Ph-negative chronic myeloproliferative neoplasms in Belarus;Russian journal of hematology and transfusiology;2023-11-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3